KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $12.3 million.

  • CareDx's Cash from Investing Activities rose 18572.12% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 1868.82%. This contributed to the annual value of -$483000.0 for FY2024, which is 10119.42% down from last year.
  • CareDx's Cash from Investing Activities amounted to $12.3 million in Q3 2025, which was up 18572.12% from $23.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Cash from Investing Activities registered a high of $41.4 million during Q4 2023, and its lowest value of -$156.0 million during Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was $1.3 million (2025), whereas its average is -$5.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 91782.06% in 2022, then skyrocketed by 184278.48% in 2023.
  • CareDx's Cash from Investing Activities (Quarter) stood at -$7.8 million in 2021, then surged by 131.8% to $2.5 million in 2022, then surged by 1571.39% to $41.4 million in 2023, then crashed by 105.1% to -$2.1 million in 2024, then surged by 684.98% to $12.3 million in 2025.
  • Its Cash from Investing Activities stands at $12.3 million for Q3 2025, versus $23.4 million for Q2 2025 and $1.3 million for Q1 2025.